Lenzing's Balance-Sheet Reset Puts Shareholders at a Crossroads

Lenzing launched a €300M rights issue at €8.65 per share, a 42.5% discount. Shares fell 5.5% to €13.02, matching a 52-week low.

Lenzing has launched the subscription period for its fully underwritten rights issue, a €300 million gross cash call designed to shore up a balance sheet strained by the fibre maker's "Grow Nonwovens, Reset Textiles" strategic overhaul. The transaction, which opened on Tuesday, will see 34,756,362 new shares placed at €8.65 apiece — a price the company says sits 42.50% below the theoretical ex-rights level.

Existing holders receive nine new shares for every ten they already own. Those wanting to take part have until 20 October 2026 to exercise their rights, while investors preferring to exit the process can trade those rights on the exchange through 14 October 2026.

The scale of the discount reflects just how much persuasion Lenzing needs to get the deal across the line. Yet the proceeds themselves are not in doubt: the B&C Group, pulp producer Suzano and Oberbank have all committed to exercising their full entitlements, guaranteeing the capital inflow. Management intends to use the fresh money to pare down debt and widen its financial room for manoeuvre as it reshapes the core business.

Market Skepticism Builds

That reassurance has done little to lift the mood. Lenzing shares came under heavy selling pressure on Tuesday, sliding 5.5% to €13.02 — exactly matching the stock's 52-week low. The prospect of a flood of new paper hitting the market has kept buyers on the sidelines, compounding the downward pressure.

Analysts have been quick to react. Berenberg downgraded the stock from "Buy" to "Hold" on Friday, with analyst Sebastian Bray pointing to a mix of headwinds: higher cotton and viscose prices that have failed to feed through to operating results as hoped, persistent raw-material costs, rising interest rates, and nagging doubts over whether Suzano will deepen its commitment to the Austrian group. The broker slashed its price target to €17.00 from €29.50.

The cautious stance was echoed by reporting from Austrian news agency APA, which flagged sharp price declines once the shares began trading ex-rights on Friday. Pre-market indications put the stock at €13.72, hovering close to its 52-week trough of €13.14, with a market capitalisation of €720.51 million.

There was movement in the shareholder register as well. A voting-rights notification showed NN Group touching a reporting threshold, leaving the group with a 2.54% stake in Lenzing.

What Comes Next

Attention now turns to the company's third-quarter figures, scheduled for release on 5 November 2026. That interim report should offer the clearest picture yet of whether earnings power and the cost base are genuinely improving under current industry conditions — and whether the €300 million injection is doing the work management intends.